Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
One of the biggest advances in pancreatic cancer in decades came out of a crazy idea born in a Harvard University lab.
Read the full articleYou might also wanna read
Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment
Researchers in Spain have developed a therapy protocol that could revolutionize the treatment of pancreatic cancer.
Lab Study Finds Compound Stops 90% of Pancreatic Cancer Cell Migration
Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, is particularly deadly and hard to treat.
Lab Study Finds Compound Stops 90% of Pancreatic Cancer Cell Migration
Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, is particularly deadly and hard to treat.
Pancreatic cancer drug daraxonrasib nearly doubles median survival in clinical trials
The pancreatic-cancer drug could be the first of an entirely new class of treatments

Scientists discover an unexpected way to make pancreatic cancer cells self-destruct
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading c
Promising pancreatic cancer drug may unlock new class of treatments targeting cancer's master switch
A promising drug could be the first of an entirely new class of treatments
A Promising Pancreatic Cancer Discovery
Jordan Winter, MD discusses his research breakthroughs to identify a metabolic enzyme, IHD1, in pancreatic cancer and how this led to findin

Comments
Sign in to join the conversation.
No comments yet. Be the first.